Protocol No.

167931 (MCLA-158-CL01)

Principal Investigator

Florou, Vaia

Phase

I/II

Age Group

Adult

ClinicalTrials.Gov

NCT03526835 (Click to jump to clinicaltrials.gov)

Title

Phase 1/2 dose escalation and cohort expansion study evaluating MCLA-158(petosemtamab) as single agent or in combination in advanced solid tumors

Objective